The Academy of Sciences of the Czech Republic (AS CR) established a new public research institution, the Institute of Biotechnology AS CR, v. v. i. The primary ambition of this new institute is to develop cutting-edge basic and oriented research on topics opening for diagnostic and therapeutic applicatons in human medicine. In particular, the institute was established to serve as a nucleation center of BIOCEV, the joined Biotech & Biomed Research Center of the Academy of Sciences with Charles University, to be built at Vestec near Prague by the year 2012 with the support of the European Regional Development Funds in frame of the Operational Program R&D for Innovation., Peter Šebo, -red-., and Tři otázky pro ředitele připravila -red-